Digital Health Transition in Rheumatology: A Qualitative Study.

chronic disease content analysis digital health eHealth fishbowl discussion patient perspective qualitative research remote care rheumatology telemedicine

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
05 03 2021
Historique:
received: 20 01 2021
revised: 27 02 2021
accepted: 02 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 13 4 2021
Statut: epublish

Résumé

The global COVID-19 pandemic has led to drastic changes in the management of patients with rheumatic diseases. Due to the imminent risk of infection, monitoring intervals of rheumatic patients have prolonged. The aim of this study is to present insights from patients, rheumatologists, and digital product developers on the ongoing digital health transition in rheumatology. A qualitative and participatory semi-structured fishbowl approach was conducted to gain detailed insights from a total of 476 participants. The main findings show that digital health and remote care are generally welcomed by the participants. Five key themes emerged from the qualitative content analysis: (1) digital rheumatology use cases, (2) user descriptions, (3) adaptation to different environments of rheumatology care, and (4) potentials of and (5) barriers to digital rheumatology implementation. Codes were scaled by positive and negative ratings as well as on micro, meso, and macro levels. A main recommendation resulting from the insights is that both patients and rheumatologists need more information and education to successfully implement digital health tools into clinical routine.

Identifiants

pubmed: 33807952
pii: ijerph18052636
doi: 10.3390/ijerph18052636
pmc: PMC7967307
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Ann Rheum Dis. 2017 Jun;76(6):948-959
pubmed: 27979873
BMJ Open. 2019 Feb 12;9(2):e023731
pubmed: 30760515
Arthritis Care Res (Hoboken). 2018 Mar;70(3):353-360
pubmed: 28511288
Ann Rheum Dis. 2019 May;78(5):713-714
pubmed: 30389688
Ann Rheum Dis. 2010 Apr;69(4):631-7
pubmed: 20215140
Ann Rheum Dis. 2020 Nov 6;:
pubmed: 33158877
Z Rheumatol. 2020 Apr;79(3):276-279
pubmed: 32103342
JMIR Mhealth Uhealth. 2020 May 15;8(5):e17507
pubmed: 32348258
Z Rheumatol. 2019 Oct;78(8):692-697
pubmed: 31468164
BMC Health Serv Res. 2020 Dec 1;20(1):1108
pubmed: 33261602
JMIR Mhealth Uhealth. 2020 Aug 12;8(8):e19661
pubmed: 32678796
Z Rheumatol. 2020 Dec;79(10):1078-1085
pubmed: 33201305
BMJ Support Palliat Care. 2020 Nov 26;:
pubmed: 33243824
Ann Rheum Dis. 2020 Sep;79(9):1139-1140
pubmed: 32527863
Rheumatol Int. 2020 Dec;40(12):2031-2037
pubmed: 32995894
PLoS One. 2018 Nov 14;13(11):e0207292
pubmed: 30427924
Semin Arthritis Rheum. 2016 Dec;46(3):380-385
pubmed: 27395561
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
J Med Internet Res. 2021 Mar 29;23(3):e23742
pubmed: 33690147
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
RMD Open. 2020 Oct;6(3):
pubmed: 33011680
RMD Open. 2021 Feb;7(1):
pubmed: 33622673
Ann Rheum Dis. 2020 Jun 24;:
pubmed: 32581084
Ann Rheum Dis. 2020 Dec 15;:
pubmed: 33323355
Rheumatology (Oxford). 2020 Dec 07;:
pubmed: 33284974
Rheumatol Int. 2018 Nov;38(11):1949-1957
pubmed: 29713795
JMIR Mhealth Uhealth. 2020 Jul 20;8(7):e18117
pubmed: 32390592

Auteurs

Felix Mühlensiepen (F)

Center for Health Services Research, Brandenburg Medical School Theodor Fontane, 15562 Rüdersdorf, Germany.
Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, 14476 Potsdam, Germany.

Sandra Kurkowski (S)

Department of Palliative Medicine, CCC Erlangen-EMN, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Martin Krusche (M)

Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.

Johanna Mucke (J)

Policlinic and Hiller Research Unit for Rheumatology, Heinrich-Heine-University, 40225 Duesseldorf, Germany.

Robert Prill (R)

Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, 14476 Potsdam, Germany.
Department of Orthopaedics and Trauma Surgery, Brandenburg Medical School Theodor Fontane, Municipal Clinic Brandenburg, 14770 Brandenburg, Germany.

Martin Heinze (M)

Center for Health Services Research, Brandenburg Medical School Theodor Fontane, 15562 Rüdersdorf, Germany.
Department of Psychiatry and Psychotherapy, Brandenburg Medical School Theodor Fontane, Immanuel Klinik Rüdersdorf, 15562 Rüdersdorf, Germany.

Martin Welcker (M)

Medizinisches Versorgungszentrum für Rheumatologie Dr. M. Welcker GmbH, 82152 Planegg, Germany.

Hendrik Schulze-Koops (H)

Division of Rheumatology and Clinical Immunology, Department of Medicine IV, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.

Nicolas Vuillerme (N)

AGEIS, Faculty of Medicine, Université Grenoble Alpes, 38706 Grenoble, France.
Institut Universitaire de France, 75006 Paris, France.
LabCom Telecom4Health, Université Grenoble Alpes & Orange Labs, 38400 Grenoble, France.

Georg Schett (G)

Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany.
Deutsches Zentrum für Immuntherapie, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Johannes Knitza (J)

AGEIS, Faculty of Medicine, Université Grenoble Alpes, 38706 Grenoble, France.
Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany.
Deutsches Zentrum für Immuntherapie, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH